Status:
COMPLETED
Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Haemophilia A, Haemophilia B, Obesity
Eligibility:
All Genders
18+ years
Brief Summary
An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a disti...
Eligibility Criteria
Inclusion
- Meeting one of the following criteria: a) Adults (any gender) aged equal to or more than 18 years with hemophilia (any severity, with or without inhibitors) self-identified with obesity or overweight, - OR - Caregivers of children (any gender) currently aged less than18 years with hemophilia (any severity, with or without inhibitors) caregiver-identified with obesity or overweight, - OR - Spouses or partners of adults (any gender) aged equal to or more than 18 years with hemophilia (any severity, with or without inhibitors) self-identified with obesity or overweight - OR - Healthcare professional (pediatric or adult hematologist, nurse, nurse practitioner, physician assistant, physical therapist, social worker) actively working in a federally designated hemophilia-treatment center for at least 3 years and with experience managing patients with hemophilia and obesity or overweight.
- Participants must have access to the internet, either at home or at a location convenient to them
- Provision of informed consent before the start of any survey-related activities.
Exclusion
- Inability to understand and comply with written instructions in English
- Previous completion of this study with receipt of compensation
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 29 2018
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT03430154
Start Date
December 1 2017
End Date
April 29 2018
Last Update
September 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Plainsboro, New Jersey, United States, 08536